Novartis reported $4.66B in Trade Creditors for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Amgen AMGN:US $ 1171M 106M
Biogen BIIB:US $ 427.9M 52.6M
Bristol Myers Squibb BMY:US $ 2695M 914M
Canopy Growth Corp WEED:CN C$ 94.37M 3.03M
Catalent CTLT:US $ 363M 22M
Corcept Therapeutics CORT:US $ 6.56M 2.66M
Eli Lilly And LLY:US $ 1566.8M 31M
Endo International Ordinary Shares ENDP:US $ 111.04M 7.2M
Gw Pharmaceuticals GWPH:US $ 16.67M 5.2M
Horizon Pharma HZNP:US $ 50.72M 1.22M
JAZZ PHA JAZZ:US $ 63.82M 1.01M
Lannett LCI:US $ 36.99M 7.4M
Novartis NOVN:VX 4.66B 146M
Pacira Pharmaceuticals PCRX:US $ 7.9M 4.28M
Perrigo Ordinary Shares PRGO:US $ 405.6M 3.2M
Phibro Animal Health PAHC:US $ 66.81M 1.56M
Prestige Brands PBH:US $ 38.05M 7.08M
Teva Pharmaceutical Industries TEVA:US $ 1514M 37M
Valeant Pharmaceuticals VRX:CN $ 455M 13M
Zoetis ZTS:US $ 387M 18M